Package Insert: Information for the Patient
Cortcal 50 micrograms/g + 0.5 mg/g Ointment
calcipotriol/betamethasone
Read this entire package insert carefully before starting to use this medication, as it contains important information for you.
Contents of the package and additional information
Cortcal is used on the skin to treat plaque psoriasis (psoriasis vulgaris) in adults. The cause of psoriasis is the excessively rapid production of skin cells. This causes redness, scaling, and thickening of the skin.
Cortcal contains calcipotriol and betamethasone. Calcipotriol helps to normalize the rate of growth of skin cells and betamethasone reduces inflammation.
Do not use Cortcal:
Sincethis medicationcontains a potent steroid, DO NOT use it on the skin affected by:
Warnings and precautions
Consult your doctor or pharmacist before starting to usecalcipotriol/betamethasone ointmentif:
Special precautions
Contact your doctor if you experience blurred vision or other visual disturbances.
Children
Cortcal is not recommended for use in children under 18 years old.
Use of Cortcal with other medications
Inform your doctor or pharmacist if you are using, have used recently or may need to use any other medication, including over-the-counter medications.
Pregnancy, breastfeeding and fertility
Do not usecalcipotriol/betamethasone ointmentif you are pregnant (or think you may be) or breastfeeding, unless your doctor has previously agreed to it. If your doctor agrees that you can breastfeed, be careful and do not applycalcipotriol/betamethasone ointmentto the breast area.
If you are pregnant or breastfeeding, think you may be pregnant or intend to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and operating machinery
This medication does not affect your ability to drive or operate machinery.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again.
How to apply this medication: Topical use.
Instructions for proper use
Treatment duration
If you use other medications containing calcipotriol, the total amount of medications containing calcipotriol should not exceed 15 grams per day, and the treated area should not exceed 30% of the total body surface area.
What to expect when using Cortcal?
Most patients notice obvious results in 2 weeks, even if the psoriasis has not yet faded at that time.
If you use more Cortcal than you should
Consult your doctor if you have used more than 15 grams per day.
Excessive use ofcalcipotriol/betametasona ointmentmay cause a problem with your blood calcium levels, which usually normalize when you stop treatment.
Your doctor may need to perform blood tests to evaluate whether excessive use of the ointment has caused a problem with your blood calcium levels.
Prolonged and excessive use may also cause your adrenal glands to malfunction (located near the kidneys and produce hormones).
If you have used morecalcipotriol/betametasona ointmentthan you should, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount used.
If you forgot to use Cortcal
Do not use a double dose to compensate for the missed doses.
If you interrupt treatment with Cortcal
The use of this medication should be discontinued as indicated by your doctor. It may be necessary to gradually discontinue the use of this medication, especially if you have been using it for a long time.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Severe side effects
Inform your doctor/nurse immediately or as soon as possible if you experience any of the following severe side effects. You may need to stop treatment.
The following severe side effects have been reported for calcipotriol/betametasona:
Rare (may affect up to 1 in 100 people)
Very rare (may affect up to 1 in 1,000 people)
It is known that some severe side effects are caused by betametasona (a powerful steroid), one of the components of this medicine. If you experience any of the severe side effects, inform your doctor as soon as possible. These side effects are more likely to occur after long-term use, when used in skin folds (e.g. elbows, armpits or under the breasts), when covered or when used on large areas of skin.
The side effects include the following:
Severe side effects caused by calcipotriol
Mild side effects
The following mild side effects have been reported for calcipotriol/betametasona:
Mild side effects common (may affect up to 1 in 10 people)
Rare (may affect up to 1 in 100 people)
Very rare (may affect up to 1 in 1,000 people)
Frequency unknown (frequency cannot be estimated from available data)
Mild side effects caused by the use of betametasona, especially over a long period, include the following. If you notice any of them, inform your doctor or nurse as soon as possible.
Mild side effects caused by calcipotriol include
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Medicines for Human Use Pharmacovigilance System https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the box and the tube after CAD. The expiration date is the last day of the month indicated.
Do not store above 25°C. Do not refrigerate or freeze.
The tube mustbe discarded after 1 year after its first opening. Write the date of the first tube opening in the space indicated for this on the box.
Medicines should not be thrown down the drains or in the trash. Deposit the containers and medicines you do not need at the SIGREpoint of the pharmacy. If in doubt, ask your pharmacist how to dispose of the containers and medicines you do not need. In this way, you will help protect the environment.
Composition of Betcal
One gram of ointment contains 50 micrograms of calcipotriol (as monohydrate) and 0.5 mg of betamethasone (as dipropionate).
Appearance of the product and content of the container
Betcal is a whiteish-colored ointment.
The ointment is presented in aluminum/epoxyphenol tubes with a polyethylene or polypropylene screw cap.
Container sizes: tubes containing 15 g, 30 g, 60 g, or 120 g of ointment.
Only some container sizes may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Galenicum Derma, S.L.
Crta N-1, Km 36,
28750 San Agustin de Guadalix (Madrid)
Spain
Responsible for manufacturing
Lek Pharmaceuticals d.d.
Verovskova ulica, 57
1526 Ljubljana
Slovenia
or
Salutas Pharma GmbH
Lange Goehren 3
D-39171, Suelzetal
Germany
or
Salutas Pharma GmbH
Otto-von-Guericke-Allee 1
39179 Barleben Germany
Last review date of this leaflet: November 2021
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.